Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (1y) (2010 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (1y) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 100.17% |
| Dec 31, 2017 | 110.32% |
| Sep 30, 2017 | -23.06% |
| Jun 30, 2017 | 262.38% |
| Mar 31, 2017 | -2,155.99% |
| Dec 31, 2016 | -771.18% |
| Sep 30, 2016 | -11.82% |
| Jun 30, 2016 | 79.08% |
| Mar 31, 2016 | 2.78% |
| Dec 31, 2015 | 13.25% |
| Sep 30, 2015 | 28.18% |
| Jun 30, 2015 | -36.74% |
| Mar 31, 2015 | -42.63% |
| Dec 31, 2014 | -65.93% |
| Sep 30, 2014 | -80.15% |
| Jun 30, 2014 | -15.77% |
| Mar 31, 2014 | 28.95% |
| Dec 31, 2013 | 221.15% |
| Sep 30, 2013 | 312.05% |
| Jun 30, 2013 | 67.97% |